XML 40 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 28, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Allocated Employee Stock-Based Compensation Expense
We allocated the stock-based compensation expense for our equity incentive plans and our 2000 Employee Stock Purchase Plan (“ESPP”) as follows (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Research and development
$
3,169

 
$
1,663

 
$
9,102

 
$
4,741

Selling, general and administrative
6,573

 
3,626

 
19,228

 
10,288

Total stock-based compensation
$
9,742

 
$
5,289

 
$
28,330

 
$
15,029

Weighted Average Grant-Date Fair Value of Stock Options and ESPP Purchases
We used a Monte Carlo simulation pricing model to value stock options that include market vesting conditions and a Black-Scholes Merton option pricing model to value other stock options and ESPP purchases. The weighted average grant-date fair value per share of stock options and ESPP purchases were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Stock options
$
8.67

 
$
11.75

 
$
9.13

 
$
10.32

ESPP
$
6.19

 
$
6.85

 
$
6.96

 
$
5.29

Valuation Assumptions Used to Estimate Grant-Date Fair Value
The grant-date fair value of stock option grants and ESPP purchases was estimated using the following assumptions:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Stock options:
 
 
 
 
 
 
 
Risk-free interest rate
2.91
%
 
1.70
%
 
2.83
%
 
1.68
%
Dividend yield
%
 
%
 
%
 
%
Volatility
55
%
 
58
%
 
55
%
 
61
%
Expected life
4.4 years

 
4.0 years

 
4.4 years

 
4.1 years

ESPP:
 
 
 
 
 
 
 
Risk-free interest rate
2.11
%
 
1.14
%
 
1.74
%
 
0.88
%
Dividend yield
%
 
%
 
%
 
%
Volatility
51
%
 
55
%
 
52
%
 
61
%
Expected life
6 months

 
6 months

 
6 months

 
6 months

Stock Option Activity
Activity for stock options during the nine months ended September 30, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Exercise Price Per Share
 
Weighted
Average
Remaining Contractual
Term
 
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2017
22,208,446

 
$
6.83

 
 
 
 
Granted
3,022,113

 
$
19.52

 
 
 
 
Exercised
(2,083,457
)
 
$
5.01

 
 
 
 
Forfeited
(216,522
)
 
$
14.40

 
 
 
 
Expired
(5,548
)
 
$
18.62

 
 
 
 
Options outstanding at September 30, 2018
22,925,032

 
$
8.59

 
3.9 years
 
$
226,821

Exercisable at September 30, 2018
15,896,370

 
$
5.03

 
3.1 years
 
$
203,118

RSU Activity
Activity for RSUs during the nine months ended September 30, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Grant Date
Fair Value Per Share
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 2017
3,762,990

 
$
17.76

 
 
 
 
Awarded
2,411,245

 
$
18.50

 
 
 
 
Vested and released
(374,992
)
 
$
8.18

 
 
 
 
Forfeited
(249,362
)
 
$
18.64

 
 
 
 
RSUs outstanding at September 30, 2018
5,549,881

 
$
18.69

 
2.1 years
 
$
98,344